Cinepazet
An overview of the pharmaceutical drug Cinepazet
| Cinepazet | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit | edit source]
Cinepazet is a pharmaceutical compound used primarily for its vasodilator properties. It is often prescribed to improve blood flow and reduce symptoms associated with peripheral vascular disease.
Pharmacology[edit | edit source]
Cinepazet functions by relaxing the smooth muscles in the blood vessels, leading to their dilation. This action helps to increase blood flow and reduce blood pressure. The mechanism of action involves the inhibition of calcium channels, which are crucial for muscle contraction.
Clinical Uses[edit | edit source]
Cinepazet is indicated for the treatment of conditions such as intermittent claudication, a symptom of peripheral artery disease characterized by pain and cramping in the lower limbs due to inadequate blood flow. It may also be used in other conditions where improved blood circulation is beneficial.
Side Effects[edit | edit source]
Common side effects of Cinepazet include headache, dizziness, and nausea. In some cases, patients may experience hypotension or tachycardia. It is important for patients to be monitored for these adverse effects, especially when starting the medication.
Contraindications[edit | edit source]
Cinepazet should not be used in patients with a known hypersensitivity to the drug. Caution is advised in patients with severe cardiovascular disease or those who are taking other medications that affect blood pressure.
Administration[edit | edit source]
Cinepazet is typically administered orally in tablet form. The dosage and frequency depend on the specific condition being treated and the patient's response to the medication.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
